Frederic Ors

Guest Contributor
April 18, 2016

Frederic Ors has been appointed CEO of Immunovaccine Inc, a Halifax-based developer of cancer immunotherapies and infectious diseases vaccines. Bergen was Immunovaccine's chief business officer and was acting CEO for the past month. He heads the firm as it transitions from an R&D-centric firm to one focused on commercialization. Prior to joining the firm, Ors was VP business development & strategic planning at Quebec City-based Medicago, an affiliate of Mitsubishi Pharma. He holds a BSC in biology and a MSc in management of intellectual property projects in biotechnology....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.